BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 26234740)

  • 1. Intravenous Ketamine for Rapid Opioid Dose Reduction, Reversal of Opioid-Induced Neurotoxicity, and Pain Control in Terminal Care: Case Report and Literature Review.
    Winegarden J; Carr DB; Bradshaw YS
    Pain Med; 2016 Apr; 17(4):644-9. PubMed ID: 26234740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency, Outcomes, and Associated Factors for Opioid-Induced Neurotoxicity in Patients with Advanced Cancer Receiving Opioids in Inpatient Palliative Care.
    Lim KH; Nguyen NN; Qian Y; Williams JL; Lui DD; Bruera E; Yennurajalingam S
    J Palliat Med; 2018 Dec; 21(12):1698-1704. PubMed ID: 30260731
    [No Abstract]   [Full Text] [Related]  

  • 3. Prolonged perioperative infusion of low-dose ketamine does not alter opioid use after pediatric scoliosis surgery.
    Pestieau SR; Finkel JC; Junqueira MM; Cheng Y; Lovejoy JF; Wang J; Quezado Z
    Paediatr Anaesth; 2014 Jun; 24(6):582-90. PubMed ID: 24809838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphine and hydromorphone-induced hyperalgesia in a hospice patient.
    Juba KM; Wahler RG; Daron SM
    J Palliat Med; 2013 Jul; 16(7):809-12. PubMed ID: 22925158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methadone-Induced Neurotoxicity in Advanced Cancer: A Case Report.
    Hoff AM; Hartwig KN; Rosielle DA
    J Palliat Med; 2017 Sep; 20(9):1042-1044. PubMed ID: 28488910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful reversal of hyperalgesia/myoclonus complex with low-dose ketamine infusion.
    Forero M; Chan PS; Restrepo-Garces CE
    Pain Pract; 2012 Feb; 12(2):154-8. PubMed ID: 21676160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postoperative analgesia and early rehabilitation after total knee replacement: a comparison of continuous low-dose intravenous ketamine versus nefopam.
    Aveline C; Gautier JF; Vautier P; Cognet F; Hetet HL; Attali JY; Leconte V; Leborgne P; Bonnet F
    Eur J Pain; 2009 Jul; 13(6):613-9. PubMed ID: 18793861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Case report: efficacy and tolerability of ketamine in opioid-refractory cancer pain.
    Amin P; Roeland E; Atayee R
    J Pain Palliat Care Pharmacother; 2014 Sep; 28(3):233-42. PubMed ID: 25102039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The addition of ketamine to a morphine nurse- or patient-controlled analgesia infusion (PCA/NCA) increases analgesic efficacy in children with mucositis pain.
    James PJ; Howard RF; Williams DG
    Paediatr Anaesth; 2010 Sep; 20(9):805-11. PubMed ID: 20716072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ketamine for perioperative pain management in children: a meta-analysis of published studies.
    Dahmani S; Michelet D; Abback PS; Wood C; Brasher C; Nivoche Y; Mantz J
    Paediatr Anaesth; 2011 Jun; 21(6):636-52. PubMed ID: 21447047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subanesthetic ketamine infusions for the management of pediatric pain in non-critical care settings: An observational analysis.
    Masaracchia MM; Sites BD; Lee J; Thomas JJ; Fernandez PG
    Acta Anaesthesiol Scand; 2019 Oct; 63(9):1225-1230. PubMed ID: 31313291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioid-sparing effect of preemptive bolus low-dose ketamine for moderate sedation in opioid abusers undergoing extracorporeal shock wave lithotripsy: a randomized clinical trial.
    Gharaei B; Jafari A; Aghamohammadi H; Kamranmanesh M; Poorzamani M; Elyassi H; Rostamian B; Salimi A
    Anesth Analg; 2013 Jan; 116(1):75-80. PubMed ID: 23223117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying risk factors for opioid-induced neurotoxicity in cancer patients receiving oxycodone.
    Omoto T; Asaka J; Nihei S; Kudo K
    Support Care Cancer; 2023 Mar; 31(4):208. PubMed ID: 36907927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is There a Role for Intravenous Subdissociative-Dose Ketamine Administered as an Adjunct to Opioids or as a Single Agent for Acute Pain Management in the Emergency Department?
    Motov S; Rosenbaum S; Vilke GM; Nakajima Y
    J Emerg Med; 2016 Dec; 51(6):752-757. PubMed ID: 27693070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful Treatment of Opioid-Refractory Cancer Pain with Short-Course, Low-Dose Ketamine.
    Waldfogel JM; Nesbit S; Cohen SP; Dy SM
    J Pain Palliat Care Pharmacother; 2016 Dec; 30(4):294-297. PubMed ID: 27754734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ketamine and Cognitive Behavioral Therapy for Rapid Opioid Tapering With Sustained Opioid Abstinence: A Case Report and 1-Year Follow-up.
    Ocker AC; Shah NB; Schwenk ES; Witkowski TA; Cohen MJ; Viscusi ER
    Pain Pract; 2020 Jan; 20(1):95-100. PubMed ID: 31408575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ketamine infusion for sickle cell pain crisis refractory to opioids: a case report and review of literature.
    Uprety D; Baber A; Foy M
    Ann Hematol; 2014 May; 93(5):769-71. PubMed ID: 24232306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioid use in cancer pain. Is a more liberal approach enhancing toxicity?
    Daeninck PJ; Bruera E
    Acta Anaesthesiol Scand; 1999 Oct; 43(9):924-38. PubMed ID: 10522740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A systematic review of ketamine as an analgesic agent in adult burn injuries.
    McGuinness SK; Wasiak J; Cleland H; Symons J; Hogan L; Hucker T; Mahar PD
    Pain Med; 2011 Oct; 12(10):1551-8. PubMed ID: 21880111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opioid-sparing effect of intravenous outpatient ketamine infusions appears short-lived in chronic-pain patients with high opioid requirements.
    Kapural L; Kapural M; Bensitel T; Sessler DI
    Pain Physician; 2010; 13(4):389-94. PubMed ID: 20648208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.